Fresenius SE reported quarterly results that narrowly missed expectations as pricing pressure in China weighed on its clinical nutrition business. First-quarter earnings rose by 6% to €678 million ($795 million) before interest and taxes and on constant currency terms, the German company said Wednesday. That was below the €686 million average of analyst estimates compiled by Bloomberg. Revenue als...
Fresenius SE reported quarterly results that narrowly missed expectations as pricing pressure in China weighed on its clinical nutrition business. First-quarter earnings rose by 6% to €678 million ($795 million) before interest and taxes and on constant currency terms, the German company said Wednesday. That was below the €686 million average of analyst estimates compiled by Bloomberg. Revenue also grew slightly less than expected, even as strong performance in its Helios hospital business and intravenous drug unit Kabi supported overall growth. Fresenius confirmed its outlook for the year. Chief Executive Officer Michael Sen has been reshaping the company’s once-sprawling portfolio and is trying to drive profit by focusing on two units — Kabi, which makes biosimilars, medical devices and intravenous drugs, and the Helios hospital business. He reduced the company’s stake in dialysis provider Fresenius Medical Care AG last year. The hospital business, which is active in Spain and Germany, saw steady patient activity and benefited from surcharges on publicly insured patients in Germany. The unit has implemented an efficiency program that generated roughly €100 million in cost savings in 2025, following the end of energy-relief funding last year. Kabi, the more profitable unit, was supported by its biosimilar portfolio — copy-cat versions of off-patent drugs. The rheumatoid arthritis treatment Tyenne was a key driver, with strong uptake in the US and Europe. However, the unit was weighed down by pricing pressure in China, where a state tender reduced revenues for medical nutrition product Ketosteril. Helios could face headwinds from planned German healthcare reforms, which aim to curb cost growth across the system. While Fresenius acknowledged the sector pressure, it sees Helios as well positioned due to discipline on costs and investments in artificial intelligence. Fresenius also said it’s investing in Avelios Medical together with SAP SE , Europe’s largest software ...
Lumine Group press release ( LMN:CA ): Q1 GAAP EPS of $0.07. Revenue increased 17% to $208.3 million compared to $178.7 million in Q1 2025 (including -2% organic growth after adjusting for foreign exchange impacts). Cash flows from operations decreased $20.3 million to $19.8 million compared to $40.1 million in Q1 2025, representing an decrease of 51%. More on Lumine Group Lumine Group's Synchrono...
Lumine Group press release ( LMN:CA ): Q1 GAAP EPS of $0.07. Revenue increased 17% to $208.3 million compared to $178.7 million in Q1 2025 (including -2% organic growth after adjusting for foreign exchange impacts). Cash flows from operations decreased $20.3 million to $19.8 million compared to $40.1 million in Q1 2025, representing an decrease of 51%. More on Lumine Group Lumine Group's Synchronoss Acquisition And Compressed Valuation Warrant A Contrarian 'Buy' Historical earnings data for Lumine Group Financial information for Lumine Group
Sany Heavy Industry Co. is considering an initial public offering for one of its units in Hong Kong, according to people familiar with the matter. The electric truck maker, Hunan Xingbida Network Technology Co. , could raise about $500 million in an IPO, the people said, asking not to be identified because the information is private. Deliberations are ongoing, they said. Sany Heavy didn’t respond ...
Sany Heavy Industry Co. is considering an initial public offering for one of its units in Hong Kong, according to people familiar with the matter. The electric truck maker, Hunan Xingbida Network Technology Co. , could raise about $500 million in an IPO, the people said, asking not to be identified because the information is private. Deliberations are ongoing, they said. Sany Heavy didn’t respond to requests for comment. Read More: Chinese Truck Drivers Are Going Electric as Gas Prices Soar Competitor Xuzhou XCMG Automobile Manufacturing Co. is also exploring a listing in Hong Kong to raise as much as $500 million, people familiar with the considerations said last week . Sany Heavy raised about HK$13.5 billion ($1.7 billion) in an October share sale in Hong Kong, the world’s top market for IPOs. After gaining as much as 49%, the shares are now up only about 3% since their debut. Sany Heavy’s been listed in mainland China much longer. It has a market value of nearly $28 billion. Almost $20 billion has already been raised in Hong Kong IPOs this year. Some of the billion-dollar-plus listings include Nvidia Corp. supplier Victory Giant Technology Huizhou Co., Muyuan Foods Co. and Eastroc Beverage Group Co.
Chinese heavy equipment manufacturer Sany Group is considering a Hong Kong initial public offering for its electric truck business, according to people familiar with the matter. The electric truck maker, Hunan Xingbida Network Technology Co. , could raise about $500 million in an IPO, the people said, asking not to be identified because the information is private. Deliberations are ongoing, they s...
Chinese heavy equipment manufacturer Sany Group is considering a Hong Kong initial public offering for its electric truck business, according to people familiar with the matter. The electric truck maker, Hunan Xingbida Network Technology Co. , could raise about $500 million in an IPO, the people said, asking not to be identified because the information is private. Deliberations are ongoing, they said. Sany didn’t respond to requests for comment. Read More: Chinese Truck Drivers Are Going Electric as Gas Prices Soar Competitor Xuzhou XCMG Automobile Manufacturing Co. is also exploring a listing in Hong Kong to raise as much as $500 million, people familiar with the considerations said last week . Sany Group’s main listed arm, Sany Heavy Industry Co. , raised about HK$13.5 billion ($1.7 billion) in an October share sale in Hong Kong, the world’s top market for IPOs. The Hong Kong-traded shares jumped 8% Wednesday, their biggest intraday gain since April 8. Sany Heavy is also listed in mainland China and has a market value of $28 billion. Almost $20 billion has already been raised in Hong Kong IPOs this year. Some of the billion-dollar-plus listings include Nvidia Corp. supplier Victory Giant Technology Huizhou Co., Muyuan Foods Co. and Eastroc Beverage Group Co.
(RTTNews) - Suncor Energy (SU) reported first quarter net income of C$2.1 billion compared to C$1.7 billion, prior year. Earnings per share was C$1.77 compared to C$1.36. Adjusted operating earnings increased to C$2.3 billion from C$1.6 billion. Adjusted operating EPS was C$1.93
(RTTNews) - Suncor Energy (SU) reported first quarter net income of C$2.1 billion compared to C$1.7 billion, prior year. Earnings per share was C$1.77 compared to C$1.36. Adjusted operating earnings increased to C$2.3 billion from C$1.6 billion. Adjusted operating EPS was C$1.93
York Water press release ( YORW ): Q1 GAAP EPS of $0.33 misses by $0.08 . Revenue of $20.07M (+8.7% Y/Y) misses by $0.83M . More on York Water York Water: Dividends Minted Since 1816 210 Years Of Dividends: York Water Western states look to desalination deals as Colorado River crisis deepens: WSJ Small-Cap rutility stocks ranked by quant ratings after earnings season Seeking Alpha’s Quant Rating o...
York Water press release ( YORW ): Q1 GAAP EPS of $0.33 misses by $0.08 . Revenue of $20.07M (+8.7% Y/Y) misses by $0.83M . More on York Water York Water: Dividends Minted Since 1816 210 Years Of Dividends: York Water Western states look to desalination deals as Colorado River crisis deepens: WSJ Small-Cap rutility stocks ranked by quant ratings after earnings season Seeking Alpha’s Quant Rating on York Water
Equinor (OSE:EQNR, NYSE:EQNR) delivered an adjusted operating income* of USD 9.77 billion and USD 2.86 billion after tax* in the first quarter of 2026. Equinor reported a net operating income of USD 8.78 billion and a net income of USD 3.10 billion. Adjusted net income* was USD 3.70 billion, leading to adjusted earnings per share* of USD 1.48.
Equinor (OSE:EQNR, NYSE:EQNR) delivered an adjusted operating income* of USD 9.77 billion and USD 2.86 billion after tax* in the first quarter of 2026. Equinor reported a net operating income of USD 8.78 billion and a net income of USD 3.10 billion. Adjusted net income* was USD 3.70 billion, leading to adjusted earnings per share* of USD 1.48.
Equinor (OSE:EQNR, NYSE:EQNR) leverte et justert driftsresultat* på 9,77 milliarder USD og 2,86 milliarder USD etter skatt* i første kvartal 2026. Det rapporterte driftsresultatet var 8,78 milliarder USD, og resultatet for perioden var 3,10 milliarder USD. Det justerte resultatet* var 3,70 milliarder USD, som ga et justert resultat per aksje* på 1,48 USD.
Equinor (OSE:EQNR, NYSE:EQNR) leverte et justert driftsresultat* på 9,77 milliarder USD og 2,86 milliarder USD etter skatt* i første kvartal 2026. Det rapporterte driftsresultatet var 8,78 milliarder USD, og resultatet for perioden var 3,10 milliarder USD. Det justerte resultatet* var 3,70 milliarder USD, som ga et justert resultat per aksje* på 1,48 USD.
Topicus.com press release ( TOI:CA ): Q1 revenue increased 23% (5% organic growth) to €435.7 million compared to €355.6 million in Q1 2025. Net income decreased to €55.1 million (€0.41 on a diluted per share basis) from €70.1 million (€0.54 on a diluted per share basis). Cash flows from operations increased €9.0 million to €280.5 million compared to €271.4 million in Q1 2025 representing an increa...
Topicus.com press release ( TOI:CA ): Q1 revenue increased 23% (5% organic growth) to €435.7 million compared to €355.6 million in Q1 2025. Net income decreased to €55.1 million (€0.41 on a diluted per share basis) from €70.1 million (€0.54 on a diluted per share basis). Cash flows from operations increased €9.0 million to €280.5 million compared to €271.4 million in Q1 2025 representing an increase of 3%. More on Topicus.com Historical earnings data for Topicus.com Financial information for Topicus.com
Viemed Healthcare press release ( VMD ): Q1 GAAP EPS of $0.06 misses by $0.03 . Revenue of $75.41M (+27.5% Y/Y) beats by $1.01M . Adjusted EBITDA for the quarter ended March 31, 2026 totaled $14.3 million, a 12% increase as compared to the quarter ended March 31, 2025. Net cash provided by operating activities totaled $8.1 million for the quarter and $57.1 million for the trailing twelve months en...
Viemed Healthcare press release ( VMD ): Q1 GAAP EPS of $0.06 misses by $0.03 . Revenue of $75.41M (+27.5% Y/Y) beats by $1.01M . Adjusted EBITDA for the quarter ended March 31, 2026 totaled $14.3 million, a 12% increase as compared to the quarter ended March 31, 2025. Net cash provided by operating activities totaled $8.1 million for the quarter and $57.1 million for the trailing twelve months ended March 31, 2026. Free cash flow totaled $2.6 million for the quarter and $36.3 million for the trailing twelve months ended March 31, 2026. The company's ventilator patient count totaled 12,089 as of March 31, 2026, an increase of 2% over March 31, 2025. Updated Full Year 2026 Guidance (all dollar amounts are USD): The Company is updating its full-year 2026 guidance to reflect increased forecasting precision and favorable trends in new patient starts, which support a narrowing of the revenue range. The Company is also updating its net capital expenditure outlook to reflect the continued shift in revenue mix toward less capital-intensive service lines, which is producing a structurally lower level of capital intensity than originally anticipated. Adjusted EBITDA guidance is reaffirmed. Net revenue is now expected to be in the range of $312 million to $320 million vs. cnsensus of $315.45M , narrowed and raised from the prior range of $310 million to $320 million. Adjusted EBITDA is expected to be in the range of $65 million to $69 million. Net capital expenditures are now expected to be in the range of 9% to 10.5% of net revenue, updated from the prior range of 10% to 11.5%. More on Viemed Healthcare Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript Viemed Healthcare, Inc. 2025 Q4 - Results - Earnings Call Presentation Viemed Healthcare Q1 Earnings Preview Viemed Healthcare reports mixed Q4 results; introduces FY26 outlook Seeking Alpha’s Quant Rating on Viemed Healthcare
Erik Isakson Blue Owl Capital ( OWL ) is evaluating a potential sale of the Asia operations of its portfolio company Stack Infrastructure in a deal that could exceed $30B, according to a Bloomberg report that cites people familiar with the matter. Stack is exploring options including a partial or full divestment of assets across key Asia-Pacific markets such as Australia, Japan, and Malaysia. The ...
Erik Isakson Blue Owl Capital ( OWL ) is evaluating a potential sale of the Asia operations of its portfolio company Stack Infrastructure in a deal that could exceed $30B, according to a Bloomberg report that cites people familiar with the matter. Stack is exploring options including a partial or full divestment of assets across key Asia-Pacific markets such as Australia, Japan, and Malaysia. The discussions with prospective advisers are at an early stage, and no final decision has been made, the report added . Other infrastructure-focused funds and industry players might be interested in Stack, as the appetite for data center assets in Asia remains robust. Denver-based Stack operates a network of data centers across major Asia-Pacific hubs, including Tokyo, positioning it to benefit from hyperscale and enterprise demand in the region. Deal activities around data centers have been prominent; in April, Bain Capital was seeking to sell at least 40% of Bridge Data Centres at $5B. While AirTrunk has engaged banks for a potential Singapore REIT listing that could raise over $1B later this year. This potential transaction comes weeks after Blue Owl ( OWL ) told investors it would limit withdrawals from two funds following a surge in redemption requests in Q1, underscoring pressure across the private credit sector. Private credit managers have faced heightened scrutiny amid a recent market downturn, as investor concerns over valuations and underwriting standards. More on Blue Owl Capital Blue Owl Capital: Getting 1,000 Shares Of Exposure At A Fraction Of The Cost Blue Owl: No Distress Detected Blue Owl: Time To Get Really Greedy Blue Owl set for growth as private credit fears overdone, Burdis says—CNBC interview Blue Owl sold half of its stake in SpaceX at a $1.25T valuation